4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001781450-25-000005
PRESIDENT AND CEO bought 56,000 shares at $1.81 ($101,360)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bashan Dror PRESIDENT AND CEO | 2025-12-19 | Purchase | +56,000 | $1.81 | $101,360 | 188,516 | D |
| Open-market purchases · 56,000 sh · avg $1.81 · $101,360 | |||||||
Loading xslF345X05/form4-12232025_121255.xml…